Manojkumar Sadasivuni

Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats

Nagesh Gowda, Anilkumar Dandu, Jaideep Singh et al. · BMC Pharmacology and Toxicology · 2013 · 26 citations · Full text

Medicine, Endocrinology, Pharmacology +17

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients

Sunil Venkategowda, Mahesh Kumar Verma, Anup Mammen Oommen et al. · BMC Pharmacology and Toxicology · 2014 · 23 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits

Anil Mathew Tharappel, Anilkumar Dandu, KrishnaReddy Harsha et al. · BMC Pharmacology and Toxicology · 2014 · 19 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17